1. Mechanisms and Functions of MiR-200 Family in Hepatocellular Carcinoma
   Yinqi Mao et al, 2021, OncoTargets and Therapy CrossRef
2. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma
   Fang-Hui Ren et al, 2018, BMC Cancer CrossRef
3. Targeting CDK6 in cancer: State of the art and new insights
   Solomon Tadesse et al, 2015, Cell Cycle CrossRef
4. MicroRNAs involved with hepatocellular carcinoma (Review)
   BIJING MAO et al, 2015, Oncology Reports CrossRef
5. Small RNA sequencing and identification of Andrographis paniculata miRNAs with potential cross‑kingdom human gene targets
   Harsha Motwani et al, 2023, Functional & Integrative Genomics CrossRef
6. Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma
   Zhu-qing Zhang et al, 2014, Diagnostic Pathology CrossRef
7. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity
   Lingyan Yuan et al, 2019, Gene CrossRef
8. Circulating miR-210 and miR-1246 as potential biomarkers for differentiating hepatocellular carcinoma from metastatic tumors in the liver
   Emad K. Ahmed et al, 2019, Journal of Medical Biochemistry CrossRef
9. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
   Saranya Chidambaranathan-Reghupaty et al, 2021, Mechanisms and Therapy of Liver Cancer CrossRef
10. MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis
    Song He et al, 2015, Clinics and Research in Hepatology and Gastroenterology CrossRef
11. Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis
    Yue Zhang et al, 2017, Oncotarget CrossRef
12. Nicotine Promotes WRL68 Cells Proliferation Due to the Mutant p53 Gain-of-Function by Activating CDK6-p53-RS-PIN1-STAT1 Signaling Pathway
    Huai Wang et al, 2020, Chemical Research in Toxicology CrossRef
13. Prognostic Role of the MicroRNA-200 Family in Various Carcinomas: A Systematic Review and Meta-Analysis
    Jung Soo Lee et al, 2017, BioMed Research International CrossRef
14. Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells
    Jianlin Wang et al, 2015, Tumor Biology CrossRef
15. Cancer Hallmarks and MicroRNAs: The Therapeutic Connection
    Katrien Van Roosbroeck et al, 2017, miRNA and Cancer CrossRef
16. microRNAs: Key players in virus‐associated hepatocellular carcinoma
    Javid Sadri Nahand et al, 2019, Journal of Cellular Physiology CrossRef
17. MicroRNA-200a Suppresses Cell Invasion and Migration by Directly Targeting GAB1 in Hepatocellular Carcinoma
    Jianlin Wang et al, 2017, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
18. The Computational Analysis of Single Nucleotide Associated with MicroRNA Affecting Hepatitis B Infection
    Mirza Ali Nazarnezhad et al, 2022, MicroRNA CrossRef
19. Research on miRNA-195 and target gene CDK6 in oral verrucous carcinoma
    Z Deng et al, 2017, Cancer Gene Therapy CrossRef
20. Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets
    Marcel Klingenberg et al, 2017, Journal of Hepatology CrossRef
21. miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6
    Huaqiang Zhu et al, 2016, Biomedicine & Pharmacotherapy CrossRef
22. The contribution of feedback loops between miRNAs, cytokines and growth factors to the pathogenesis of psoriasis
    Moamen Masalha et al, 2018, Experimental Dermatology CrossRef
23. MicroRNA200a enhances antitumor effects in combination with doxorubicin in hepatocellular carcinoma
    Xiao Cui et al, 2020, Translational Oncology CrossRef
24. MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells
    Matthew L. Potter et al, 2021, Bone CrossRef
25. Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets
    Jinghang Xu et al, 2020, Frontiers in Oncology CrossRef